We are live on ! Find out more
GCA

Genesee Capital Advisors Portfolio holdings

AUM $239M
1-Year Est. Return 20.45%
This Fund
S&P 500
This Quarter Est. Return
+3.57%
1 Year Est. Return
+20.45%
3 Year Est. Return
+71.53%
5 Year Est. Return
+85.18%
10 Year Est. Return
AUM
$168M
AUM Growth
+$15.8M
Cap. Flow
+$12M
Cap. Flow %
7.1%
Top 10 Hldgs %
45.44%
Holding
99
New
14
Increased
41
Reduced
30
Closed
8

Top Sells

Rank Stock Value
1
TGTX icon
TG Therapeutics
TGTX
+$3.21M
2
CALX icon
Calix
CALX
+$1.91M
3
WMT icon
Walmart Inc
WMT
+$1.88M
4
SFIX
Stitch Fix
SFIX
+$1.64M
5
CYRX icon
CryoPort
CYRX
+$1.56M

Sector Composition

Rank Sector Weight
1 Technology 11.15%
2 Healthcare 8.3%
3 Industrials 5.95%
4 Consumer Discretionary 5.79%
5 Financials 4.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CALX icon
26
Calix
CALX
$2.26B
$2.17M 1.29%
62,679
-51,650
-45% -$1.91M
SFIX
27
Stitch Fix
SFIX
$536M
$2.17M 1.29%
43,853
-23,288
-35% -$1.64M
ADSK icon
28
Autodesk
ADSK
$49.5B
$2.16M 1.28%
7,796
+345
+5% +$99.5K
CYRX icon
29
CryoPort
CYRX
$761M
$2.15M 1.28%
41,440
-25,595
-38% -$1.56M
MA icon
30
Mastercard
MA
$502B
$2.14M 1.27%
6,006
+291
+5% +$102K
CSX icon
31
CSX Corp
CSX
$93.4B
$2.09M 1.24%
+65,133
New +$1.99M
ADBE icon
32
Adobe
ADBE
$99.5B
$2.06M 1.22%
4,326
+67
+2% +$31.3K
TDOC icon
33
Teladoc Health
TDOC
$1.22B
$2.01M 1.19%
11,043
+9,788
+780% +$2.27M
CCXI
34
DELISTED
ChemoCentryx, Inc.
CCXI
$1.87M 1.11%
36,492
+8,316
+30% +$500K
ZM icon
35
Zoom
ZM
$28.2B
$1.78M 1.06%
5,538
+1,694
+44% +$623K
MSFT icon
36
Microsoft
MSFT
$3.45T
$1.75M 1.04%
7,434
+522
+8% +$121K
MCD icon
37
McDonald's
MCD
$192B
$1.15M 0.68%
5,142
-88
-2% -$18.8K
BND icon
38
Vanguard Total Bond Market
BND
$157B
$1.08M 0.64%
12,724
+1,345
+12% +$116K
META icon
39
Meta Platforms (Facebook)
META
$1.42T
$988K 0.59%
3,355
+333
+11% +$89.7K
HON icon
40
Honeywell
HON
$77B
$958K 0.57%
4,682
-942
-17% -$184K
QCOM icon
41
Qualcomm
QCOM
$155B
$936K 0.56%
7,063
-2,134
-23% -$308K
BNDW icon
42
Vanguard Total World Bond ETF
BNDW
$1.88B
$933K 0.55%
11,720
+27
+0.2% +$2.18K
BLK icon
43
Blackrock
BLK
$169B
$915K 0.54%
1,213
-103
-8% -$74.7K
CCL icon
44
Carnival Corporation Ltd
CCL
$38.1B
$907K 0.54%
+34,186
New +$806K
CMI icon
45
Cummins
CMI
$87.5B
$901K 0.53%
3,476
-50
-1% -$12.5K
ITB icon
46
iShares US Home Construction ETF
ITB
$2.26B
$891K 0.53%
13,126
-1,426
-10% -$88K
RIO icon
47
Rio Tinto
RIO
$158B
$875K 0.52%
11,262
-2,668
-19% -$219K
SOXX icon
48
iShares Semiconductor ETF
SOXX
$41.7B
$874K 0.52%
6,183
-1,104
-15% -$151K
IYC icon
49
iShares US Consumer Discretionary ETF
IYC
$1.17B
$873K 0.52%
11,671
+943
+9% +$68.6K
IYW icon
50
iShares US Technology ETF
IYW
$23.6B
$858K 0.51%
9,784
-743
-7% -$65.1K

Similar funds

Genesee Capital Advisors's Q1 2021 Portfolio in Review

As of Q1 2021, Genesee Capital Advisors held 99 positions worth $168M, up 10% from $153M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Genesee Capital Advisors deployed $12M of net new capital in Q1 2021, opening 14 new positions and adding to 41 existing holdings. Its largest new stake was First Trust NASDAQ-100 Technology Index Fund: 45,787 shares worth $6.6M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 14% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Calix, an estimated $1.91M trimmed.

  • Genesee Capital Advisors's largest Q1 2021 buy was First Trust NASDAQ-100 Technology Index Fund: 45,787 shares worth $6.6M.
  • Genesee Capital Advisors added most to Teladoc Health in Q1 2021, an estimated $2.27M increase.
  • Genesee Capital Advisors's biggest Q1 2021 reduction was Calix, cutting an estimated $1.91M.
  • Genesee Capital Advisors fully exited TG Therapeutics in Q1 2021, selling an estimated $3.21M.
  • Genesee Capital Advisors's ten largest holdings make up 45% of its $168M portfolio in Q1 2021.
  • Genesee Capital Advisors opened 14 new positions and closed 8 in Q1 2021.
  • Genesee Capital Advisors's portfolio value rose 10% quarter-over-quarter to $168M.

Based on Genesee Capital Advisors's 13F filing for Q1 2021, filed 16 Apr 2021.